ArticleBMC infectious diseases2026

Nucleocapsid protein enhances spike- and RBD-specific humoral and cellular immune responses in protein-based SARS-CoV-2 vaccine.

Stina Gröhn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.